Subsequently, ADAMTS9 was suggested as a novel tumour suppressor based on its remarkable activities in inducing apoptosis and inhibiting cell proliferation and angiogenesis in nasopharyngeal, gastric, colorectal, pancreatic and cervical cancers 12, 13, 14, 15, 16. This evidence concerns the gene ADAMTS9 and neoplasm.